Session topics and Invited Speakers at EuPAT 13
September 28-30 • 2026 • Ghent • Belgium
28th September – Workshop TBD
29th September – Session 1 Next-generation sensors, advanced PAT tools and innovative QbD strategies, supporting real-time monitoring, intelligent control and robust, flexible manufacturing across batch, mini-batch and continuous processes
29th September – Session 2 Integrated and autonomous pharmaceutical platforms, connecting drug substance and drug product development through end-to-end manufacturing
30th September – Session 3 Artificial intelligence across the pharmaceutical lifecycle, enabling predictive modeling, data-driven decision making and autonomous operation
Programme
Here you can donwload the first version of the program soon.
28 September – CESPE industry-focused session: PAT in Practice: Implementation Challenges, Measurable Impact and Real Outcomes
This session will be dedicated to the industrial use-cases of PAT, focused on the practical challenges of implementing PAT and its sustainability dimension: does PAT truly reduce environmental and operational footprint, and how can its impact be measured objectively?
By addressing both the potential benefits and the practical barriers to implementation, the session provides a realistic, end-to-end view that complements and sets the stage for EuPAT’s focus on intelligent and autonomous manufacturing.
28 September – EuPAT/CESPE workshop
Join experts for a hands-on session designed to showcase the latest equipment and technologies used in pharmaceutical development and manufacturing. The workshop will feature demonstration booths by leading technology providers, including real-world case studies of PAT implementation and advanced process monitoring.
Participants will also have the opportunity to explore the new core facility in The Nucleus, offering an exclusive look at the advanced infrastructure supporting research and innovation.
29 September – Session 1: “- Next-generation sensors, advanced PAT tools and innovative QbD strategies, supporting real-time monitoring, intelligent control and robust, flexible manufacturing across batch, mini-batch and continuous processes”
Prof. Dr. Axel Zeitler / University of Cambridge, UK Terahertz Porosity Sensing for Disintegration Prediction
Dr. Tom Van den Kerkhof, Johnson & Johnson Innovative Medicine, Control Strategies and Real-Time Release for Continuous Manufacturing: Case Studies
Jan-Sebastiaan Uyttersprot, Union Chimique Belge, BE, TBD
29 September – Session 2: “- Integrated and autonomous pharmaceutical platforms, connecting drug substance and drug product development through end-to-end manufacturing”
Prof. Dr. Ossi Korhonen, School of Pharmacy - University of Eastern Finland, FI, Continuous Direct Compression in Development of Dispersible Combination Tablet for HIV-positive Pediatric Patients
Dr. Jérôme Mantanus - Dr. Efty Hadjittofis, Union Chimique Belge, BE, Particle Engineering as an Enabler for Continuous Flow Processing
30 September – Session 3: “Artificial intelligence across the pharmaceutical lifecycle, enabling predictive modeling, data-driven decision making and autonomous operation”
Prof. Dr. Daniel Markl, University of Strathclyde, GB, From Material, Process, and Product Knowledge to the AI Formulator
Prof. Dr. Kārlis Bērziņš, University of Copenhagen, DK, Predictive Pharmaceutical Development and Process Intelligence through Low-Frequency Vibrational Spectroscopy
Participants are encouraged to Submit Abstracts for poster presentations, whilst selected scientists from submitted abstracts will be invited to give oral presentations alongside the keynote speakers!
